Patients N (%) | ASAQ | AL | p-value |
---|---|---|---|
N = 496 | N = 502 | ||
AEs “possibly related to study drug” | 382 (77.0) | 348 (69.3) | 0.006 |
AEs ≥ grade 3 | 17 (3.4) | 8 (1.6) | 0.064 |
Fatigue (pooled) ** | 200 (39.8) | 81 (16.3) | <0.001 |
Abdominal pain | 29 (5.8) | 18 (3.6) | 0.091 |
Diarrhoea | 20 (4.0) | 14 (2.8) | 0.279 |
Vomiting | 35 (7.1) | 8 (1.6) | <0.001 |
Vomiting after drug intake | 2 (0.4) | 0 | 0.247* |
Nausea | 16 (3.2) | 5 (1.0) | 0.015* |
Hepatotoxicity *** | 23 (4.6) | 31 (6.3) | 0.283 |
Rash | 4 (0.8) | 0 | 0.061* |
Itching | 0 | 0 | - |
Abnormal movements (Dystonia) | 0 | 0 | - |
Neutropaenia | 94 (19.0) | 110 (21.9) | 0.246 |
Anaemia | 74 (14.9) | 49 (9.8) | 0.013 |
Thrombocytopaenia | 4 (0.8) | 0 | 0.061* |